ODOBGYNDECODED

← Clinical library

Obstetrics

Breech Presentation & ECV

IN REVIEWv3🌍 International referencePENDING CLINICAL VERIFICATION
Offer ECV 36+0 wks (nullip) / 37+0 (multip): success ~50-60%. Vaginal breech only for selected cases by experienced attenders under strict criteria; otherwise planned caesarean ~39 wks.

Admission & discharge ↓

Reviewer note: Medication regimens and dependent emergency instructions checked 17 October 2026. These targeted checks do not certify every statement in the module. Admission/discharge guidance checked 18 October 2026. This adds a scoped clinical synthesis and does not certify every statement in the module.

Clinical detail

Additional detail checked 2026-10-17 against the linked sources. This check covers the section below; the rest of the module retains its displayed verification status.

A breech finding near term leads to a discussion of external cephalic version and birth options. The decision depends on the pregnancy, available expertise and the patient’s preferences.

Assessment & interpretation

  • Confirm presentation with ultrasound and review fetal wellbeing, placental location, fluid and relevant obstetric history.
  • Explain what ECV involves, its chance of success and the small possibility of needing urgent delivery.

Decisions that change management

  • ECV is performed in a setting with ultrasound, fetal-heart assessment and access to emergency caesarean birth. Contraindications and suitability require obstetric review.
  • If ECV is declined or unsuccessful, discuss planned caesarean and carefully selected vaginal breech birth where an appropriately skilled team is available.

Follow-up & safety-netting

  • Check the fetal heart before and after ECV. RhD-negative patients may need anti-D and follow-up testing after the procedure.
  • Give return instructions for pain, bleeding, reduced movements, labour or fluid loss. Confirm presentation again if needed before a planned operation.

Clinical pitfalls

  • An attempted version is not appropriate for every breech pregnancy. A discussion of vaginal breech birth must include the local team’s skills and ability to respond to complications.
Sources for this detail:

Admission & discharge

Care setting: Usually outpatient planning; ECV in a unit with emergency caesarean access

Admission/discharge guidance checked 2026-10-18 against the linked sources. This is a clinical checklist for an individual decision, not an automatic discharge order.

When admission or continued hospital care is needed

  • Bleeding, labour, membrane rupture, abnormal fetal assessment or maternal instability needs hospital evaluation/admission; ECV complications require immediate obstetric care.

When clinic, day care or home care may be suitable

  • Stable breech presentation can be managed through antenatal review and a documented ECV/birth plan.

Before going home

  • After ECV, maternal observations and the required fetal monitoring are reassuring; no persistent pain, bleeding or other complication is present.
  • Document whether ECV succeeded, RhD/anti-D assessment and the plan if labour starts before the next review.

Discharge medicines and treatment changes

  • Record any tocolytic given and indicated anti-D; do not provide a routine home tocolytic course after ECV.

Tests, pending results and their reviewer

  • Record presentation and pre/post-procedure fetal assessment; organise confirmation/review if required.

Home care and counselling

  • Give clear advice about fetal movements, pain, bleeding and membrane rupture, and the planned place/mode of birth.

Follow-up: when and what to review

WhenAction / responsible service
At the booked review
Confirm presentation and finalise the birth plan after successful or unsuccessful ECV.
If labour or waters break
Contact the maternity unit promptly rather than waiting for the next appointment.

Return urgently

  • Bleeding, persistent abdominal pain, reduced movements, contractions or rupture of membranes after ECV require immediate maternity contact.

Open the complete discharge checklist →

Treatment

① Immediate stabilization — first minutes
ECV emergencies (rare): Transient FHR changes common -> stop/reposition/observe; persistent pathological CTG -> emergency caesarean capability mandatory wherever ECV is performed.
③ First-line treatment & drug regimens
Terbutaline — ECV onlyNHS Greater Glasgow and Clydechecked
Dose250 micrograms, 10 minutes before ECV
RouteSubcutaneous
FrequencyOne pre-procedure dose
DurationOne ECV attempt episode; not a maintenance preterm-labour regimen
Preparation0.5 mg/mL ampoule: withdraw 0.5 mL =250 micrograms. This row is SC, not an interchangeable IV bolus
Max dose250 micrograms for the cited ECV regimen; no automatic repeat
  • Hospital external cephalic version after eligibility assessment, consent and baseline CTG
  • Assess RhD status and provide indicated anti-D after ECV.
Monitoring
  • Maternal pulse/BP before treatment and pulse 5 minutes after; fetal assessment/CTG and immediate caesarean capability
Contraindications: Cardiac disease; caution in diabetes and pre-eclampsia; ECV contraindications must be excluded
  • Technique: US-guided forward-roll/backward-flip; abandon after 2-3 attempts
  • Failed/refused ECV -> PLANNED CAESAREAN at 39+0 wks standard recommendation
  • SELECTED vaginal breech birth (expert centre criteria): frank/complete breech, adequate pelvis on clinical assessment, normal growth, flexed head on imaging, continuous monitoring, experienced operator + assistant, informed choice, immediate-caesarean availability
Definitive treatment
  • Successful version -> standard care
  • Planned caesarean 39 wks or selected vaginal breech with intrapartum rules
Monitoring
ContextWatch
Post-ECV
CTG 30 min minimum before discharge
Labouring breech (selected)
Continuous CTG; progress strict; anaesthetist aware; neonatal team present
Treatment failure
  • Entangled cord/prolapse in labour -> cord-prolapse emergency pathway
Escalation
  • Any breech labour outside expert criteria -> convert to caesarean early rather than rescue late
⑮ Complications & their management
Cord entanglement/prolapse

Emergency pathway

Entrapment of aftercoming head

McRoberts + episiotomy + forceps to aftercoming head (Piper); nitroglycerin uterine relaxation by anaesthesia in extreme cases

Fetal trauma

Neonatal orthopaedic/neuro review

Post-treatment care
  • Standard birth recovery
  • Document counselling trail for medico-legal clarity

Diagnosis & assessment

Definition: Pelvic pole presenting: frank/complete/footling varieties determine management.

Risk factors

GrandmultiparityUterine anomalies/fibroidsPraeviaPoly/oligohydramniosMultiplesFetal anomalies (screen)Contracted pelvis

Initial assessment

  1. Confirm type + gestation by US; exclude praevia/anomalies
  2. ECV eligibility: >=36+0 wks, no contraindications (praevia, ROM, multiples beyond twin-1, severe PET, pathological CTG, major anomaly); prior scar relative - unit policy
  3. CTG + US immediately pre-procedure

Investigations

TestLooking for
Pre-ECV CTG + US
Baseline reassurance

Principles & follow-up

Management principles

Sources (8)

NICE — Intrapartum care (NG235)
2023-09-29 · updated 2026-06-09 · checked 2026-08-23 · verified-live
Open source ↗

NICE overview + Update information page (dates above confirmed)

RCOG — Breech baby at the end of pregnancy — patient information
· checked 2026-10-18 · verified-live
Open source ↗

Scope: additional clinical-detail explanation for breech-ecv. Checked the assessment, management-decision and follow-up statements in that section against this source. This does not certify all pre-existing regimens, calculations or recommendations in the module. Additional admission/discharge check…

NHS Greater Glasgow and Clyde — External cephalic version — Clyde SOP
· checked 2026-10-18 · verified-live
Open source ↗

Terbutaline 250 micrograms SC (0.5 mL of 0.5 mg/mL) ten minutes before ECV; pulse check at five minutes, CTG, cardiac contraindication, diabetes/PE cautions and anti-D. Additional admission/discharge check 18 October 2026 (limited to the following): Institutional ECV monitoring/complication pathway …

NICE — Postnatal care — NG194
· checked 2026-10-18 · verified-live
Open source ↗

Maternal/newborn transfer assessment, first void and effective feeding, handover, support/safeguarding, first midwife visit within 36 hours after transfer, postnatal danger symptoms. Full recommendations page read.

India MoHFW / NHM — District Hospital Standard Operating Procedures — LaQshya
· checked 2026-10-18 · verified-live
Open source ↗

Normal-delivery discharge not less than 48 hours: full primary SOP PDF normal-delivery/discharge passages read. Corroborated by NHM CEmONC 2024 Part 1, chapter 8. This does not define a universal post-caesarean or complicated-case stay.

WHO — WHO recommendations on quality postnatal care — official recommendation summary
· checked 2026-10-18 · verified-live
Open source ↗

Official WHO summary read: at least 24-hour facility care after birth; additional contacts at 48–72 hours, 7–14 days and week 6; individual assessment/support. Summary facts only, not a claim that the full 242-page PDF was reviewed.

RCOG — Laparoscopy — recovering well
· checked 2026-10-18 · verified-live
Open source ↗

Full primary patient recovery page read: pain control, wounds, activity/VTE, urinary/bowel and infection warning signs, adult support and no driving/important decisions during the first 24 hours after general anaesthesia. Used as general recovery/handover principles, not operation-specific discharge…

NICE — Acutely ill adults in hospital — CG50
· checked 2026-10-18 · verified-live
Open source ↗

Full primary recommendations read, focusing on critical-care-to-ward transfer: structured written handover, shared plan, monitoring, rehabilitation and receiving-team capability. Step-down is distinct from home discharge; no universal organ-support discharge cutoff is asserted.